Colitis and Crohn’s disease, celiac disease, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS) are classified as conditions that affect the small and large intestines. All conditions except irritable bowel disease fit into the category of inflammatory conditions.
Colitis, Crohn’s disease and IBS involve not just inflammation but also irregular muscle movements and issues with water absorption in the large intestines. These issues can cause serious discomfort and a variety of other symptoms.
Research demonstrates the ability of Hemp Extract to become one of the strongest anti-inflammatory compounds currently available. Since most gastrointestinal disorders are caused or worsened by chronic inflammation, Hemp Extract is able to inhibit the production of an enzyme called fatty acid amide hydrolase (FAAH). This fatty acid essentially regulates the production (or lifespan) of endocannabinoids. When the FAAH is reduced, endocannabinoid levels are increased.
Many bowel issues are believed to be caused by endocannabinoid deficiencies. Therefore Hemp Extract is an effective treatment because it increases endocannabinoid levels.
Hemp Extract also reduces the permeability of the intestinal walls. When cells become inflamed within the stomach and intestines, they allow more fluids to pass through the gut and into the body, triggering pain, irritation and a reduction in the ability to absorb nutrients. Healing gut permeability plays a major role in reversing the wide range of gastrointestinal conditions.
Thank you for taking your time to become educated on the science and technologies behind the best health supplements.
My best wishes for your best health.
Founder and CEO of Optivida Health
[For more science-based evidence for the use of hemp extract read "Hemp Health Revolution: The A to Z Health Benefits of Hemp Extract"]
*Phytother Res. 2013 May;27(5):633-6. doi: 10.1002/ptr.4781. Epub 2012 Jul 20.
Cannabidiol in inflammatory bowel diseases: a brief overview.
*Pharmacology. 2014;93(1-2):1-3. doi: 10.1159/000356512. Epub 2013 Dec 17.
Cannabis finds its way into treatment of Crohn’s disease.
*PLoS One. 2011;6(12):e28159. doi: 10.1371/journal.pone.0028159. Epub 2011 Dec 6.
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.
*Br J Pharmacol. 2010 Jun;160(3):712-23. doi: 10.1111/j. 1476-5381.2010.00791.x.The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.